A multi-herb formulation known as Shexiang Huayu Xingnao granules significantly attenuated cerebral bleeding, accelerated neurological recovery, and protected against colonic tissue injury in a rat model of intracerebral hemorrhage, according to a preclinical investigation published in Frontiers in Microbiology. Intracerebral hemorrhage represents one of the most fatal and disabling subtypes of acute stroke worldwide, triggered by the sudden rupture of cerebral blood vessels and subsequent pooling of blood directly within the neural parenchyma. In addition to primary physical disruption of brain tissue, patients experiencing acute hemorrhagic stroke frequently suffer secondary multi-organ complications, most notably gastrointestinal dysfunction, intestinal dysbiosis, and systemic inflammatory surges. By examining both central nervous tissue and distal intestinal pathology, researchers demonstrated that oral administration of this traditional formula suppressed intracranial hematoma expansion, decreased systemic inflammatory cell mobilization, and partially re-established the compositional architecture of both bacterial and fungal communities inhabiting the gastrointestinal tract.
Hemorrhagic stroke constitutes an urgent global health priority, accounting for more than three million deaths internationally in 2021 and approximately 45.6 percent of all stroke-related fatalities. Up to half of individuals who survive the initial intracranial bleed go on to develop acute gastrointestinal disorders, including gut dysbiosis, gut motility dysfunction, and gastrointestinal bleeding. These clinical observations have focused scientific attention on the gut-brain axis, a bidirectional communication highway regulated by nervous, immune, and humoral pathways. Emerging neurovascular evidence indicates that gut microbiota disruption can exacerbate intracranial inflammatory cascades by stimulating the migration of peripheral pro-inflammatory cells into the brain, while central neural damage simultaneously impairs autonomic and vascular regulation of the intestinal barrier. Existing clinical options for intracerebral hemorrhage remain heavily restricted to acute blood pressure management, the reversal of coagulopathies, and surgical hematoma evacuation, treatments that often display inconsistent efficacy and neurotoxicity risks. Consequently, investigating therapeutic modalities capable of simultaneously protecting vulnerable neural parenchyma and stabilizing the gut-brain axis represents an important research objective.
To evaluate whether botanical interventions could target both cranial and intestinal consequences of hemorrhagic stroke, the research team analyzed the defined pharmaceutical preparation Shexiang Huayu Xingnao granules. The formula incorporates eight specific botanical and zoological components: astragalus, Sargentodoxae caulis, Notoginseng Radix et Rhizoma, musk, Cinnamomi ramulus, rhubarb, oriental water plantain rhizome, and dextrin excipient. Standardized manufacturing involved extracting water-soluble fractions through dual boiling cycles followed by filtration, concentration into a thick paste, granulation with Sanqi powder, and uniform application of ethanol-dissolved musk. To ensure batch reproducibility, the researchers conducted chromatographic quality profiling using high-performance liquid chromatography to quantify six key therapeutic markers, including ginsenoside Rb1, aloe-emodin, rhein, emodin, chrysophanol, and physcion. Across validation trials, these markers exhibited high linear correlation coefficients exceeding 0.999 and robust average recovery rates ranging between 94.79 percent and 99.72 percent, providing rigorous analytical control over the chemical consistency of the administered substance.
The experimental study utilized adult male Sprague-Dawley rats randomly assigned across five distinct study groups of six animals each: a sham surgical control group, an untreated intracerebral hemorrhage model group, and three model cohorts treated with low, medium, or high doses of the herbal formulation. Intracerebral hemorrhage was induced by stereotactically microinjecting bacterial collagenase VII directly into the right striatal brain region, reliably recapitulating the vessel rupture, continuous parenchymal bleeding, and progressive hematoma formation characteristic of human hemorrhagic stroke. Six hours following surgical lesion induction, daily therapeutic interventions commenced via oral gavage. Human-to-animal surface area dose conversions yielded experimental dosages of 2.65 grams per kilogram daily for the low-dose cohort, 5.3 grams per kilogram for the medium-dose cohort, and 10.6 grams per kilogram for the high-dose cohort, continuing over a seven-day observation period, while control and model rats received volume-matched saline placebos under blinded experimental protocols.
Assessing physiological tolerability revealed that the botanical intervention preserved vital hepatic and renal functions in the stroke-afflicted animals. Serum biochemical analyses showed that circulating levels of alanine aminotransferase and the ratio of aspartate aminotransferase to alanine aminotransferase remained statistically comparable between untreated model rats and all herbal treatment cohorts, indicating an absence of drug-induced hepatocellular toxicity. Furthermore, low-dose treatment significantly attenuated the pathological elevation of aspartate aminotransferase observed in untreated model animals. When evaluating renal clearance, serum creatinine levels exhibited no significant differences across any experimental groups, confirming stable glomerular filtration. Notably, while the induction of intracerebral hemorrhage drove significant increases in blood urea nitrogen in untreated model animals compared with healthy sham controls, all three dosages of the herbal formulation significantly reduced urea accumulation. Additionally, high-dose administration halted the progressive post-stroke systemic wasting pattern, reversing significant body weight loss by day seven.
Serial neurological evaluations utilizing the eighteen-point modified Garcia scoring system demonstrated substantial functional recovery in treated animals. Healthy sham controls maintained maximal neurological performance throughout the week-long testing schedule, whereas untreated model rats exhibited persistent neurobehavioral deficits characterized by impaired spontaneous exploration, asymmetrical posturing, weak forelimb extension, diminished wire-grid grip strength, and reduced tactile responsiveness. Animals receiving the low-dose regimen did not achieve statistically significant functional separation from untreated models. In marked contrast, rats receiving the high-dose preparation demonstrated significant neurobehavioral improvements starting on the fourth day post-surgery, maintaining superior neurological scores through day seven. Animals receiving the medium-dose regimen also achieved significant functional gains on days six and seven, confirming that sustained post-acute administration of the formulation promotes progressive neurological restoration following severe striatal hemorrhage.
Morphological and histopathological analyses of coronal brain sections illustrated clear structural protection within hemorrhagic cerebral hemispheres. Planimetric quantification of one-millimeter frozen coronal brain slices using digital image analysis revealed that while all treated cohorts exhibited a downward trend in relative hematoma size, high-dose administration produced statistically significant hematoma suppression compared with untreated models. Microscopic examination of paraffin-embedded brain slices stained with hematoxylin and eosin highlighted extensive parenchymal architectural destruction in untreated stroke models, accompanied by massive erythrocyte extravasation and dense accumulations of inflammatory neutrophils surrounding the lesion perimeter. In animals administered the herbal granule formulation, cerebral inflammatory cell infiltration was markedly diminished, and surrounding tissue distortion was visibly mitigated, confirming that the intervention limited ongoing secondary cellular damage around the primary hematoma core.
The reduction in local neural inflammation coincided with significant suppression of systemic pro-inflammatory cellular dynamics in peripheral blood. Blood samples drawn from the abdominal aorta revealed that total white blood cell counts, absolute neutrophil numbers, and the neutrophil-to-lymphocyte ratio rose significantly in untreated stroke models compared with sham animals, reflecting an intense acute systemic inflammatory cascade. Administration of the multi-herb formula produced a clear dose-dependent reduction in both total circulating white blood cells and absolute neutrophils. Furthermore, the severe lymphocyte depletion observed in untreated model animals was significantly reversed by medium-dose administration. By normalizing lymphocyte counts and dampening elevated neutrophil fractions, the treatment significantly suppressed the pathological neutrophil-to-lymphocyte ratio, indicating that the botanical compound effectively counteracted the systemic immunoinflammatory dysregulation that typically follows acute intracranial tissue disruption.
Histological examination of colonic cross-sections demonstrated that intracranial vascular trauma directly damaged the architecture of the distal gastrointestinal tract. Colon tissues harvested from healthy sham rats presented tightly organized mucosal epithelial layers, high mucosal gland density, and intact structural integrity. Conversely, tissues taken from untreated hemorrhagic stroke models exhibited pronounced histopathological degeneration, marked mucosal destruction, and disrupted glandular arrangements. Daily oral administration of the high-dose herbal formulation visibly repaired this intestinal pathology, preserving the structural architecture of the colon and restoring the continuity of mucosal barriers. These histopathological observations provided direct physical evidence that severe intracranial hemorrhage precipitates secondary colonic tissue damage, and that the administered botanical granules effectively mitigate this downstream organ injury along the gut-brain axis.
High-throughput profiling of the intestinal microbiome via 16S ribosomal RNA gene sequencing revealed that the botanical intervention altered bacterial dysbiosis induced by the neurological trauma. While alpha diversity analyses indicated that overall bacterial richness remained contracted following stroke induction across both untreated and treated animals, beta diversity calculations based on binary Jaccard distance metrics demonstrated notable structural remodeling. Non-metric multidimensional scaling plots showed that untreated stroke models diverged extensively from healthy controls, whereas bacterial communities in medium- and high-dose treatment groups shifted substantially back toward the healthy baseline profile. Permutational multivariate analysis of variance confirmed that experimental grouping accounted for 17.1 percent of the total compositional variance across cohorts. At the phylum level, the significant reduction in beneficial Bacteroidota observed in untreated stroke animals was successfully attenuated in the medium-dose cohort, suggesting that the formula helped sustain polysaccharide-fermenting bacterial lineages essential for short-chain fatty acid production.
Parallel internal transcribed spacer sequencing demonstrated that the treatment also modulated the intestinal fungal community, or mycobiome. Untreated stroke models displayed a marked decline in fungal alpha diversity, as measured by Shannon indices, whereas treatment with the herbal granules significantly elevated fungal species richness and diversity back toward sham levels. Non-metric multidimensional scaling and distance-based testing revealed significant group-level clustering across fungal profiles. Taxonomic mapping showed that the relative abundance of the phylum Ascomycota rose significantly following stroke induction but was markedly suppressed by high-dose herbal administration. Simultaneously, unclassified fungal taxa and Chytridiomycota, which were severely depleted in untreated models, exhibited dose-dependent recovery in the treated cohorts. Cross-kingdom network correlations further demonstrated that stroke induction disrupted healthy inter-kingdom relationships, precipitating abnormal negative correlations between opportunistic Aspergillus fungi and beneficial commensal bacteria such as Bacteroides and Lactobacillus.
While these preclinical findings establish a coherent physiological link between herbal intervention, hematoma resolution, and gastrointestinal preservation, the researchers emphasized essential methodological and biological limitations. The study was conducted exclusively in a collagenase-induced rat model, requiring subsequent translational validation before drawing conclusions regarding human clinical efficacy. Additionally, while the formulation clearly modulated both bacterial and fungal taxonomic proportions, definitive causal mechanisms linking specific microbial changes to neuroprotection remain unproven in the absence of fecal microbiota transplantation, germ-free animal experiments, or direct short-chain fatty acid receptor tracing. The authors also noted that future studies should incorporate active control comparators, such as minocycline, to benchmark therapeutic potency, alongside expanded profiling of circulating chemokines and inflammatory cytokines. Nonetheless, the combined data demonstrate that Shexiang Huayu Xingnao granules provide dual protection by mitigating intracerebral hematomas and ameliorating concomitant intestinal injury, offering a valuable mechanistic framework for developing comprehensive therapies directed across the gut-brain axis.
Subject of Research: Evaluation of Shexiang Huayu Xingnao granules in a rat model of intracerebral hemorrhage and concomitant colonic injury
Article Title: Therapeutic effects of Shexiang Huayu Xingnao granules on intracerebral hemorrhage and its concomitant colonic injury in rats
Article References: Liu, F., Wang, T., Yang, X., She, J., Xie, C., Liao, H., & Song, Z. (2026). Therapeutic effects of Shexiang Huayu Xingnao granules on intracerebral hemorrhage and its concomitant colonic injury in rats. Frontiers in Microbiology, 17, Article 1981989. https://doi.org/10.3389/fmicb.2026.1981989
Image Credits: AI Generated
DOI: 10.3389/fmicb.2026.1981989
Keywords: Intracerebral hemorrhage, Shexiang Huayu Xingnao granules, Traditional Chinese medicine, Gut-brain axis, Gut microbiota, Mycobiome, Neuroprotection, Sprague-Dawley rats, Modified Garcia score, Colonic histopathology, Bacteroidota, Ascomycota, Neutrophil-to-lymphocyte ratio, Collagenase model, Hematoma reduction, Trans-kingdom network
News Source: Cassandra Pierce. (November 18, 2026). Herbal Formulation Reduces Brain Bleeding and Gut Damage in Rat Stroke Model. Scienmag.



